ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

High-Risk Pharmacogenetic (PGx) Variants in Kidney Transplant (tx) Recipients.

D. Berglund,1 D. Schladt,2 K. Sanghavi,1 W. Guan,1 B. Wu,1 C. Dorr,3 R. Remmel,1 R. Mannon,4 A. Matas,1 W. Oetting,1 A. Israni,3 P. Jacobson,1 DeKAF Genomics Investigators.

1UofMN, Mpls
2MMRF, Mpls
3HCMC, Mpls
4UAB, Birmingham.

Meeting: 2016 American Transplant Congress

Abstract number: 334

Keywords: Adverse effects, Gene polymorphism, Kidney transplantation

Session Information

Date: Monday, June 13, 2016

Session Name: Concurrent Session: Medication Errors, Variability and Adherence

Session Time: 4:30pm-6:00pm

 Presentation Time: 4:54pm-5:06pm

Location: Room 302

Related Abstracts
  • Identification of Genetic Variants Associated With Variation of Tacrolimus Levels in African Americans Using GWAS
  • The Association Between Donor & Recipient Gene Variants and Tacrolimus Safety & Efficacy in a Diverse Cohort of Kidney Transplant Recipients

Kidney tx recipients carry a high burden of comorbidities, and some of the medications for these conditions have genetic predictors of efficacy and toxicity. These genes may be associated with subtherapeutic treatment, predisposition to side-effects and, in rare cases, death. However, these genetic variants are not commonly used to personalize therapy in clinical tx practice.

Recipients (n=3043) undergoing kidney tx between 2005-2011 were enrolled and followed prospectively in the DeKAF genomics multicenter study. DNA was genotyped using the Affymetrix Tx Array GWAS chip (exome panel with approx 782,000 variants) which included PGx variants. The Clinical PGx Implementation Consortium (CPIC) guidelines were reviewed and medications with genetic recommendations that may be relevant to tx recips were selected. We then evaluated our subjects for the presence of these risk gene variants.

The mean age at tx was 49±14 yrs; 62% male; 75% White, 18% African American, 4% Asian. We identified 8 relevant high-risk PGx genotypes on our chip (Table 1). These genotypes occurred in 5-57% of recips. High risk clopidogrel CYP2C19 variants were present in 29% of recips. Clopidogrel was actively prescribed at time of tx in 111 of which 24% had a high risk genotype that would confer risk for lack of efficacy. 38% of recips had a CYP2C19 risk genotype that would place them at risk for antidepressant therapy failure. 24% carried the SLCO1B1 variant which placed them at higher risk for development of simvastatin related myopathy. The genotype conveying rapid clearance of tacrolimus was present in 26%.

We found a high proportion of recipients carried high risk PGx genotypes. The CYP2C19 risk variant was present in nearly a third of our >3,000 recips and may be at risk for therapeutic failure should they receive clopidgrel or antidepressants. Genetic testing is increasingly accessible and knowing this information prior to starting these medications may improve efficacy and reduce unnecessary side effects in an already complex patient.

CITATION INFORMATION: Berglund D, Schladt D, Sanghavi K, Guan W, Wu B, Dorr C, Remmel R, Mannon R, Matas A, Oetting W, Israni A, Jacobson P, DeKAF Genomics Investigators High-Risk Pharmacogenetic (PGx) Variants in Kidney Transplant (tx) Recipients. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Berglund D, Schladt D, Sanghavi K, Guan W, Wu B, Dorr C, Remmel R, Mannon R, Matas A, Oetting W, Israni A, Jacobson P, Investigators DeKAFGenomics. High-Risk Pharmacogenetic (PGx) Variants in Kidney Transplant (tx) Recipients. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/high-risk-pharmacogenetic-pgx-variants-in-kidney-transplant-tx-recipients/. Accessed March 8, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.